PALVELLA THERAPEUTICS, INC. (PVLA)
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
Mobileye Secures Major DMS Production Program with Leading U.S. Automaker
Anavex Presents New AD-004 Phase IIb/III Data at AD/PD 2026 Showing Correlation Between Blarcamesine and Brain Volume in Alzheimer’s
Reports 2025 Financial Results and Provides Corporate Updat
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
INVESTOR NOTICE: Gartner, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
JZXN to Deliver 100 Electric Heavy-Duty Trucks to Vietnam Market
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
WeRide Reports Record Full Year 2025 Revenue of RMB684.6 Million, Up 90% Year over Year
FORM 20-F For the fiscal year ended December 31, 2025